BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 8311501)

  • 1. [A case of malignant lymphoma of the thyroid accompanied by interstitial pneumonitis during radiation therapy after systemic chemotherapy].
    Doi M; Hisada Y; Namba R; Nakata Y; Saika Y; Shimizu T; Sueyoshi K; Kawai T; Narabayashi I
    Gan To Kagaku Ryoho; 1994 Feb; 21(2):269-72. PubMed ID: 8311501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Interstitial pneumonia in patients treated with VACOP-B therapy for malignant lymphoma].
    Sakai C; Goto S; Nakaseko C; Kumagai K; Takagi T
    Gan To Kagaku Ryoho; 1998 Feb; 25(3):423-6. PubMed ID: 9492839
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug-induced pneumonitis detected earlier by 18F-FDG-PET than by high-resolution CT: a case report with non-Hodgkin's lymphoma.
    Yamane T; Daimaru O; Ito S; Nagata T; Yoshiya K; Fukaya N; Ito S; Imai T; Uchida H
    Ann Nucl Med; 2008 Oct; 22(8):719-22. PubMed ID: 18982476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatal interstitial pneumonitis related to rituximab-containing regimen.
    Herishanu Y; Polliack A; Leider-Trejo L; Grieff Y; Metser U; Naparstek E
    Clin Lymphoma Myeloma; 2006 Mar; 6(5):407-9. PubMed ID: 16640819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salvage surgery for primary non-Hodgkin's lymphoma of the thyroid gland with histopathological complete response to radio-chemotherapy: report of a case.
    Shimizu J; Ishida Y; Takehara A; Kinoshita T; Tatsuzawa Y; Kawaura Y; Matsumoto I; Imai M
    Surg Today; 2003; 33(1):45-8. PubMed ID: 12560906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Necrotizing leukoencephalopathy following CHOP chemotherapy.
    Blaes AH; Santa-Cruz KS; Lee CK; Hui SK; Peterson BA
    Leuk Res; 2008 Oct; 32(10):1611-4. PubMed ID: 18378307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case of malignant lymphoma in the skull base].
    Tanaka S; Nihei H; Manaka S; Hori T
    No Shinkei Geka; 1994 Jan; 22(1):73-8. PubMed ID: 8295707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Essential thrombocythemia after treatment of non-Hodgkin's lymphoma.
    Maciel JF; de Lourdes Chauffaille M; Inaoka RJ; Colleoni GW; Yamamoto M
    Leuk Res; 2007 Nov; 31(11):1593-5. PubMed ID: 17324461
    [No Abstract]   [Full Text] [Related]  

  • 9. [Concurrent chemo-radiotherapy for localized refractory non-Hodgkin's lymphoma--report of two cases].
    Sugimoto T; Matano S; Nishijima H; Kakuta K; Inamura K; Okamura T; Munemoto S; Satoh S
    Gan To Kagaku Ryoho; 2007 Jan; 34(1):125-8. PubMed ID: 17220687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of high-dose chemotherapy with subsequent transplantation of blood-forming cells on left ventricle function in patients with malignant lymphomas treated with doxorubicin in primary chemotherapy].
    Elbl L; Vásová I; Krejcí M; Navrátil M; Tomásková I; Jedlicka F; Chaloupka V; Mayer J; Vorlícek J
    Vnitr Lek; 2006 Mar; 52(3):221-31. PubMed ID: 16722153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of autologous stem cell transplantation with purged bone marrow as first-line therapy for follicular lymphoma with high tumor burden: a GOELAMS phase II study.
    Colombat P; Cornillet P; Deconinck E; Tourani JM; Gardembas M; Delain M; Abgrall JF; Kootz C; Milpied N
    Bone Marrow Transplant; 2000 Nov; 26(9):971-7. PubMed ID: 11100276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinically relevant pneumonitis after sequential paclitaxel-based chemotherapy and radiotherapy in breast cancer patients.
    Yu TK; Whitman GJ; Thames HD; Buzdar AU; Strom EA; Perkins GH; Schechter NR; McNeese MD; Kau SW; Thomas ES; Hortobagyi GN; Buchholz TA
    J Natl Cancer Inst; 2004 Nov; 96(22):1676-81. PubMed ID: 15547180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generalized eruptive lentiginosis induced by chemotherapy.
    De D; Dogra S; Kanwar AJ; Saikia UN
    Clin Exp Dermatol; 2010 Jun; 35(4):e113-5. PubMed ID: 19874348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Syndrome of inappropriate secretion of antidiuretic hormone and neurotoxicity induced by vincristine and alkylating agents during chemotherapy for malignant lymphoma of thyroid gland].
    Tsujita Y; Iwao N; Makino S; Ohsawa N
    Gan To Kagaku Ryoho; 1998 Apr; 25(5):757-60. PubMed ID: 9571977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increasing chemotherapy dose density and intensity: phase I trials in non-small cell lung cancer and non-Hodgkin's lymphoma.
    Blayney DW; McGuire BW; Cruickshank SE; Johnson DH
    Oncologist; 2005 Feb; 10(2):138-49. PubMed ID: 15709216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interdisciplinary treatment of the malignant lymphoma of the thyroid.
    Gyóry F; Lukács G; Balázs G; Szakáll S; Miltényi L; Kiss A
    Acta Chir Hung; 1997; 36(1-4):110-2. PubMed ID: 9408307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk and timing of hospitalization for febrile neutropenia in patients receiving CHOP, CHOP-R, or CNOP chemotherapy for intermediate-grade non-Hodgkin lymphoma.
    Lyman GH; Delgado DJ
    Cancer; 2003 Dec; 98(11):2402-9. PubMed ID: 14635075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective study of reduced-dose three-course CHOP followed by involved-field radiotherapy for patients 70 years old or more with localized aggressive non-Hodgkin's lymphoma.
    Shikama N; Oguchi M; Isobe K; Nakamura K; Tamaki Y; Hasegawa M; Kodaira T; Sasaki S; Kagami Y;
    Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):217-22. PubMed ID: 16814951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical usefulness of ondansetron hydrochloride for nausea and vomiting during repeated courses of chemotherapy for malignant lymphoma--impact of prognosis announcement on anti-emetic effect and evaluation of patient perception of chemotherapy-associated adverse events].
    Kodama F; Mohri H; Motomura S; Fukawa H; Tanabe J; Koharasawa H; Kanamori H; Hashimoto Y; Harano H; Sakai R; Tomita N; Fujimaki K; Takemura S; Hattori M
    Gan To Kagaku Ryoho; 2002 Feb; 29(2):273-9. PubMed ID: 11865634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined cyclophosphamide, vincristine, doxorubicin, and prednisone (CHOP) improves response rates but not survival and has lower hematologic toxicity compared with combined mitoxantrone, chlorambucil, and prednisone (MCP) in follicular and mantle cell lymphomas: results of a prospective randomized trial of the German Low-Grade Lymphoma Study Group.
    Nickenig C; Dreyling M; Hoster E; Pfreundschuh M; Trumper L; Reiser M; Wandt H; Lengfelder E; Unterhalt M; Hiddemann W;
    Cancer; 2006 Sep; 107(5):1014-22. PubMed ID: 16878325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.